Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
antitrust, assumption, consummate, consummated, consummation, divestiture, Durning, Eastern, enjoin, Exhibit, faith, frame, FTC, furnished, holiday, HSR, indemnification, lessening, line, merge, minute, outlook, Parent, pendency, plaintiff, Premerger, reassure, refiled, refiling, Saturday, scrutinize, seller, Sunday, tender, tendered, timetable, undertaken, voluntarily, waiting, withdrew, withholding
Removed:
advancing, ankylosing, antagonist, antibody, ascending, attributed, axial, billion, bowel, collectively, consisting, continually, COSENTYX, distinct, diversification, dose, EGC, evaluating, Fc, FcRn, half, healthy, hiring, IBD, implicated, inflammatory, ixekizumab, Kingdom, lymphopoietin, neonatal, objective, overlapping, paper, pharmacokinetic, preserve, psoriatic, receptor, secukinumab, signaling, Specifically, stromal, TALTZ, thymic, TNF, TSLP, tumor, validated
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view